Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05221606 · ClinicalTrials.gov registry record · NA

Nurse AMIE (Addressing Malignancies in Individuals Everyday)

A NA study of Cancer, sponsored by University of Pittsburgh.

Active
Registry status
NA
Development phase
344
Enrollment target
8
Study locations

NCT05221606 is a NA study of Cancer that is active but no longer recruiting, run by University of Pittsburgh. The registered enrollment target is 344 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (90% lower). The trial reports 8 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05221606, a NA study of Cancer, is active but no longer recruiting, sponsored by University of Pittsburgh.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
344 participants
Enrollment target
8
Study locations

Study Summary

Nurse AMIE 3.0 is testing the effectiveness of an electronic symptom management system on overall survival in people with stage 3 and 4 cancer who live in rural areas.

Conditions Studied

Interventions

  • BEHAVIORAL Usual Care
  • BEHAVIORAL Nurse AMIE

Study Locations (8)

Pennsylvania

  • UPMC-Butler - Butler
  • UPMC - Greenville - Greenville
  • Penn State Hershey Medical Center - Hershey
  • UPMC - Indiana - Indiana
  • UPMC - New Castle - New Castle
  • UPMC - Northwest - Seneca
  • Mount Nittany Medical Center - State College

West Virginia

  • West Virginia University - Morgantown

Trial Details

FieldValue
Enrollment Target 344 participants
Start Date 2022-05-03
Est. Completion 2027-03
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT05221606

The ClinicalTrials.gov registry entry for NCT05221606 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 344 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (90% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT05221606 reports 8 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, West Virginia.

Frequently Asked Questions

What is clinical trial NCT05221606 about?

NCT05221606 is a clinical study titled "Nurse AMIE (Addressing Malignancies in Individuals Everyday)". Nurse AMIE 3.0 is testing the effectiveness of an electronic symptom management system on overall survival in people with stage 3 and 4 cancer who live in rural areas.

What is the current status of trial NCT05221606?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 344 participants. The study started on 2022-05-03. Estimated completion is 2027-03.

What conditions does trial NCT05221606 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT05221606?

The interventions under investigation include: Usual Care (BEHAVIORAL), Nurse AMIE (BEHAVIORAL).

Who is sponsoring clinical trial NCT05221606?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05221606 being conducted?

This trial has 8 study locations across Pennsylvania, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.